Company
Headquarters: Tampa, FL, United States
Employees: 1
$475,341
USD as of July 1, 2023
| Company | Market Cap (USD) |
|---|---|
| Zoetis Inc. | $89.09 B |
| MERCK Kommanditgesellschaft auf Aktien | $67.64 B |
| Takeda Pharmaceutical Company Limited | $47.71 B |
| Haleon plc | $38.90 B |
| PPD, Inc. | $16.58 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Laxai Pharma, Ltd. offers contract research services in the United States. It provides integrated services across the drug development spectrum. The company focuses its services in the areas of biostatistics, data management (EDC, Hybrid, and Paper), CDISC consulting, medical writing, monitoring, regulatory, drug safety, and related training programs. The company was formerly known as Nexgen Biofuels Ltd. and changed its name to Laxai Pharma, Ltd. in February, 2010. Laxai Pharma, Ltd. is based in Tampa, Florida.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Laxai Pharma Ltd has the following listings and related stock indices.
Stock: OTC: LAXAF wb_incandescent
Headquarters:
8905 Regents Park Drive
Suite 210
Tampa, FL 33647
United States
Phone: 813-428-3500